The Federal Trade Commission is working to accelerate its inquiry into the prescription-drug middlemen known as pharmacy-benefit managers, while also expanding its scrutiny of drug patents that can keep prescription prices artificially high, FTC Chair Lina Khan told reporters Tuesday.
BLOOMFIELD, Conn. , April 23, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced today that Brian Evanko, executive vice president and chief financial officer, will present at the BofA Securities 2024 Health Care Conference on May 15, 2024, in Las Vegas, NV.
Healthcare stocks, especially industry leaders that offer a wide range of products and services, can be an investor's best friend due to the growing need for increased development of healthcare products and services. These stocks tend to provide investors with a substantial return on their investment.
This article focuses on selecting high-growth dividend stocks that have rapidly grown their dividends in the recent past, rather than simply sport a high current yield. We use our proprietary models to rate quantitatively and qualitatively and select the top ten names from an initial list of nearly 400 dividend stocks. The article provides criteria for selecting high-growth dividend stocks. It ...
Grant application now open for nonprofits that aim to improve youth mental health New multiyear philanthropic and community engagement initiative will also prioritize the mental health of veterans through housing stability and reducing barriers to health equity Initiative encourages employee volunteerism, and launches with volunteer events to assemble mental well-being packs for local Boys & G...
BLOOMFIELD, Conn. , April 11, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its first quarter 2024 financial results on Thursday, May 2, 2024, and will host a conference call the same day.
Company Recognized for Excellence in Health Equity BLOOMFIELD, Conn. , April 9, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) has been recognized for excellence in employee health and well-being by the Business Group on Health, and for its commitment to health equity.
The Cigna Group is one of the few companies that have outperformed the AI-fantasy-driven S&P 500 Index by a wide margin. After a 50% return in less than a year and a new all-time high, it's fair to ask whether it's wise to sell Cigna stock now. In this update, I share my view on Cigna's performance in 2023 and explain why I decided to hold on to my Cigna shares - despite the historically expens...
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.